MicroRNA-Based Delivery Systems for Chronic Neuropathic Pain Treatment in Dorsal Root Ganglion

Area of Science:

• Neuroscience
• Biotechnology
• Pharmacology

Background:

• Neuropathic pain is a complex global health issue with significant economic impact.
• MicroRNAs (miRNAs) play a role in pain signaling by regulating gene expression and macrophage polarization in dorsal root ganglia (DRG).
• Dysregulated miRNAs can promote pro-inflammatory responses, exacerbating neuropathic pain.

Purpose of the Study:

• To comprehensively analyze miRNA-based nano-systems for treating chronic neuropathic pain.
• To evaluate the impact of these systems on dorsal root ganglia.
• To explore innovative strategies for enhancing clinical translation of miRNA therapies.

Main Methods:

• Review of existing literature on miRNA-based nano-systems for neuropathic pain.
• Analysis of various nanocarrier platforms: viral, polymeric, lipid-based, and inorganic.
• Discussion of challenges and potential solutions for nucleotide delivery.

Main Results:

• Dorsal root ganglion stimulation shows effectiveness in chronic pain relief.
• miRNA dysregulation in DRG neurons leads to pro-inflammatory macrophage polarization and pain.
• Various nanocarrier systems demonstrate therapeutic potential but face delivery challenges.

Conclusions:

• miRNA-based nano-systems hold significant therapeutic potential for chronic neuropathic pain.
• Efficient and safe delivery vehicles are essential for miRNA nucleotide therapy.
• Hybrid and stimulus-responsive nanocarriers offer innovative strategies for improved clinical outcomes.